Search Results

Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.

• Authors : Talmon, Maria; Percio, Marcella; Obeng, Joyce Afrakoma

• Source: PLoS ONE. March 6, 2023, Vol. 18 Issue 3, e0282564.

Record details

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.

• Authors : Temmoku, Jumpei; Miyata, Masayuki; Suzuki, Eiji

• Source: PLoS ONE. September 19, 2022, Vol. 17 Issue 9, e0274775.

Record details

Rheumatoid arthritis can be prevented, study shows; Weekly injections of drug abatacept cut the risk of developing the auto-immune disease by 80 per cent in Lancet trial.

• Source: The Telegraph Online. February 13, 2024

Record details

Intranasal administration of abatacept enhances IL-35.sup.+ and IL-10.sup.+ producing Bregs in lung tissues of ovalbumin-sensitized asthmatic mice model.

• Authors : Alenazy, Maha Fahad; Sharif-Askari, Fatemeh Saheb; El-Wetidy, Mohammed S.

• Source: PLoS ONE. September 6, 2022, Vol. 17 Issue 9, e0271689.

Record details

Gene expression regulated by abatacept associated with methotrexate and correlation with disease activity in rheumatoid arthritis.

• Authors : Derambure, Céline; Dzangue-Tchoupou, Gaelle; D'Agostino, Maria Antonietta

• Source: PLoS ONE. August 6, 2020, Vol. 15 Issue 8, e0237143.

Record details

Cost-effectiveness of abatacept, tocilizumab and TNF-inhibitors compared with rituximab as second-line biologic drug in rheumatoid arthritis.

• Authors : Huoponen, Saara; Aaltonen, Kalle J.; Viikinkoski, Jaana

• Source: PLoS ONE. July 24, 2019, Vol. 14 Issue 7, e0220142.

Record details

Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.

• Authors : Balandraud, Nathalie; Texier, Gaetan; Massy, Emmanuel

• Source: PLoS ONE. February 15, 2017, Vol. 12 Issue 2, e0171623.

Record details

Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research.

• Authors : Maeda, Shinji; Osaga, Satoshi; Maeda, Tomoyo

• Source: PLoS ONE. November 20, 2019, Vol. 14 Issue 11, e0215192.

Record details

Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy.

• Authors : Norlin, Jenny; Nielsen Fink, Lisbeth; Helding Kvist, Peter

• Source: PLoS ONE. April 7, 2016, Vol. 11 Issue 4.

Record details

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.

• Authors : Provan, Sella Aarrestad; Berg, Inger Jorid; Hammer, Hilde Berner

• Source: PLoS ONE. June 26, 2015, Vol. 10 Issue 6.

Record details